INNOVATE
Accredited and funded projects
Between 2005 and 2011, Lyonbiopole accredited 110 R&D collaborative projects representing a total investment of € 537 million for which € 220 million of public aids were obtained from the State (FUI and ANR), Oséo, authorities* and the European Community.
* European Regional Development Fund (EDFR), the Rhone-Alpes Region, Greater Lyon, Grenoble Alpes Métropole, the County Councils of Rhône, Isère and Ain and the Grenoble city.
They speak about...
« Innovations by biotech firms still take too long to reach major pharmaceutical companies, despite the growing needs of industrial firms and their interest in these breakthroughs in the area of personalized treatment. One of the main reasons is that start ups lack networks and visibility in the eyes of these large industrial groups. These two complementary players thus need a catalyst to create meetings, pass on information and contact one another. This is what World Competitive Clusters like Lyonbiopole do. ImmunID has benefited from this effective support, and we have had excellent results in 2008 and 2009, signing contracts with several firms which are leaders in their field, such as Sanofi Pasteur. In the end, Lyonbiopole is an organization which plays an active role in setting up and giving impetus to future high potential R&D projects in the health sphere. »
Nicolas Pasqual
ImmunID Technologies - Ph.D. CEO